Ipragliflozin Add-on Therapy to a GLP-1 Receptor Agonist in Japanese Patients with Type 2 Diabetes (AGATE): A 52-Week Open-Label Study

INTRODUCTION: Few data are available regarding ipragliflozin treatment in combination with glucagon-like peptide-1 (GLP-1) receptor agonists. The aim of this study was to evaluate the efficacy and safety of ipragliflozin in combination with GLP-1 receptor agonists in Japanese patients with inadequat...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Diabetes Ther
Hlavní autoři: Ishihara, Hisamitsu, Yamaguchi, Susumu, Nakao, Ikko, Sakatani, Taishi
Médium: Artigo
Jazyk:Inglês
Vydáno: Springer Healthcare 2018
Témata:
Original Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6064587/
https://ncbi.nlm.nih.gov/pubmed/29926400
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13300-018-0455-8
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky